ROSG Key Statistics, Chart & Performance
The current stock price of ROSG is 0.43 null. In the past month the price increased by 22.86%. In the past year, price decreased by -78.06%.
About ROSG
Company Profile
Rosetta Genomics is a leader in the field of microRNA. The company's integrative research platform combining bioinformatics and state-of-the-art laboratory processes has led to the discovery of hundreds of biologically validated novel human microRNAs. Building on its strong IP position and proprietary platform technologies, Rosetta Genomics is working on the application of these technologies in the development of a full range of microRNA-based diagnostic and therapeutic tools, focusing primarily on cancer and various women's health indications.
Company Info
Rosetta Genomics Ltd
10 PLAUT STREET SCIENCE PARK
REHOVOT L3 76706
CEO: Kenneth A. Berlin
Phone: 972-73-222-0700
Rosetta Genomics Ltd / ROSG FAQ
Can you describe the business of Rosetta Genomics Ltd?
Rosetta Genomics is a leader in the field of microRNA. The company's integrative research platform combining bioinformatics and state-of-the-art laboratory processes has led to the discovery of hundreds of biologically validated novel human microRNAs. Building on its strong IP position and proprietary platform technologies, Rosetta Genomics is working on the application of these technologies in the development of a full range of microRNA-based diagnostic and therapeutic tools, focusing primarily on cancer and various women's health indications.
Can you provide the latest stock price for Rosetta Genomics Ltd?
The current stock price of ROSG is 0.43 null.
Does Rosetta Genomics Ltd pay dividends?
ROSG does not pay a dividend.
What is the ChartMill rating of Rosetta Genomics Ltd stock?
ROSG has a ChartMill Technical rating of 4 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
What is the Price/Earnings (PE) ratio of Rosetta Genomics Ltd (ROSG)?
Rosetta Genomics Ltd (ROSG) does not have a PE ratio as the earnings reported over the last twelve months were negative (-9.31).
Who owns Rosetta Genomics Ltd?
You can find the ownership structure of Rosetta Genomics Ltd (ROSG) on the Ownership tab.
ROSG Technical Analysis
ChartMill assigns a technical rating of 4 / 10 to ROSG. When comparing the yearly performance of all stocks, ROSG is a bad performer in the overall market: 85.1% of all stocks are doing better.
ROSG Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to ROSG. ROSG has a bad profitability rating. Also its financial health evaluation is rather negative.
ROSG Financial Highlights
Over the last trailing twelve months ROSG reported a non-GAAP Earnings per Share(EPS) of -9.31. The EPS increased by 32.59% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | -190.2% | ||
| ROA | -229.85% | ||
| ROE | -1298.18% | ||
| Debt/Equity | 0 |